cryptorchidism
Jump to navigation
Jump to search
Introduction
failure of testis to descend
Epidemiology
- one of the most frequent congenital abnormalities in humans, involving 2-5% of male births
Genetics
Laboratory
- serum beta-chorionic gonadotropin (serum beta-hCG)
- tumor marker most likely to be increased in young man with cryptorchidism corrected with orchidopexy[4]
- increased in 10% of seminomas
- may be increased in non-seminomas[3]
- correlates with trophoblasts within tumor
- serum alpha-fetoprotein is NEVER increased in pure seminomas
Complications
- increased risk of infertility & testicular cancer (seminoma)
Management
More general terms
Additional terms
References
- ↑ Stedmans Medical Dictionary, 26th ed., Williams & Wilkins 1995
- ↑ OMIM https://mirror.omim.org/entry/219050
- ↑ 3.0 3.1 Ferguson L, Agoulnik AI. Testicular cancer and cryptorchidism. Front Endocrinol (Lausanne). 2013 Mar 20;4:32. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23519268 PMCID: PMC3602796 Free PMC article
- ↑ 4.0 4.1 NEJM Knowledge+